Hyperglycemia is a major etiological factor causing cardiovascular dysfunction. Changes in intracellular ionic homeostasis via a series of biochemical changes initiated by hyperglycemia directly affect cellular function resulting abnormal cardiac remodeling and development of diabetic complications. Since hyperglycemia regulates free cytosolic Zn2+ ([Zn2+]i) and attenuates protein S-nitrosylation via NO-cGMP-PKG, which induces depressed cardiac contractility, in part contribution of activated β3-adrenergic receptor (β3-AR). We postulated a possible cross-talk between hyperglycemia, activation of β3-AR and NO availability, [Zn2+]i increase and contractile dysfunction. [Zn2+]i levels were determined by imaging freshly isolated adult rat cardiomyocytes from either normoglycemic or hyperglycemic rat loaded with FluoZin-3. We investigated the distribution of β-ARs subtypes by measuring the expression/protein levels of β1-, β2-, β3-AR as well as their left ventricular agonist responsiveness using isolated perfused hearts from diabetic rats. We found that hyperglycemia influenced both function and the mRNA/protein levels of selective β1- and β3-AR although the total β-AR did not change. In vitro experiments showed that β3-AR agonist (BRL-37,344) induced significant increase in [Zn2+]i while this effect was prevented with L-NAME exposure in normoglycemic cardiomyocytes. Our data demonstrated that either chronic or acute hyperglycemia initiates a series of interconnected biochemical changes in cardiomyocytes including a cross-talk between activation of β3-AR and NO signaling pathway including increased [Zn2+]i and then this cross-talk meadiates abnormal cardiac remodeling and the development of diabetic cardiomyopathy. Therefore, it can be proposed a pathway that a dynamic association of intracellular free Zn2+ with sulfur in protein cysteine clusters under hyperglycemia, from which the metal is released by NO and other thiol oxidant species is one of the mechanisms which plays important role in the Zn2+ contribution to maintaining cellular redox balance. (Supported by TUBITAK-SBAG-109S267 & 111S042)
Read full abstract